Success Stories

Nasdaq’s Opening Bell Rings for a USC Research Startup

Today, a USC-licensed startup that developed an intranasal drug delivery system for brain tumors will be listed for the first time on Nasdaq. To celebrate the direct listing, the USC Stevens Center for Innovation and the startup, NeOnc Technologies Holdings Inc., will ring the opening bell at 9:30 a.m. EDT/6:30 a.m. PDT. NeOnc is based

2025-03-27T16:04:12-07:00March 26th, 2025|

A USC Stem Cell-led Study About a New Approach for Alzheimer’s Prevention

Is Alzheimer’s something you can prevent? Scientists at Keck School of Medicine of the University of Southern California discovered a way to activate a natural cleanup system in brain cells, removing toxic tau proteins linked to memory loss. The neurotransmitter glutamate is essential for regulating everything from mood to memory, but it can also encourage

2025-03-22T08:34:30-07:00March 7th, 2025|

L-Nutra Closes $47 Million in First Stage of Growth Investment Round

Congratulations to Dr. Valter Longo, Director of the Longevity Institute at USC and his venture, L-Nutra Inc., a premier nutri-technology company leading longevity science nutrition programs, on the closure of a $47M Series D funding. The round was led by a personal investment from Stephane Bancel, CEO at Moderna Inc., alongside Brentwood Associates, a Los Angeles based middle

2023-12-06T08:54:49-08:00December 2nd, 2023|

Organic Light-Emitting Diodes (OLED)

Dr. Mark E. Thompson with his collaborators at USC and Princeton University developed organic light-emitting diode (OLED) technology that Universal Display Corporation (UDC) has advanced and commercialized into an international business.

2020-12-11T20:35:59-08:00October 9th, 2020|

Light Stage

Dr. Paul Debevec and collaborators created the Light Stages to make believable digital doubles for movies, television, video games and immersive simulations by capturing and simulating how objects and people reflect any possible lighting.

2020-12-11T20:07:36-08:00October 9th, 2020|

Argus II Retinal Prosthesis

The Argus II Retinal Prosthesis system is the first FDA-approved implanted electronic device to re-establish some functional vision in blind patients.

2021-03-08T19:25:56-08:00October 9th, 2020|